Axa SA ADR Fair Value: 39.9% Upside to $71.37

Axa SA ADR Fair Value Analysis: 39.9% Upside Potential

Axa SA ADR (AXAHY) is a leading global insurer offering property & casualty, life, health, and asset management solutions across Europe, Asia, and the Americas. At a recent price of USD 51, our fair value estimate stands at USD 71.37, pointing to substantial upside of +39.9% and a Quality Score of 66/100. This positions AXAHY as undervalued on our multi-model valuation framework.

Company Overview and Recent Performance

AXA operates one of the world's largest insurance franchises with diversified revenue streams. In Q1 2026 the group delivered robust results, with revenues rising 6% to EUR 38 billion, driven by balanced growth in Property & Casualty and Life & Health segments. The company maintains a strong Solvency II ratio of 224% and continues to return capital via dividends and buybacks. Upcoming earnings on or around July 30-31, 2026, will provide further updates on 2026 guidance.

Why Our Model Flags Axa SA ADR as Undervalued

Our fair value of USD 71.37 incorporates 21 valuation models, including discounted cash flow, dividend discount, and residual income approaches, adjusted for AXA's Quality Score. Key drivers include its high dividend yield near 5.3%, expected EPS growth of 6-8% annually, and improving investment yields in a higher-rate environment. The current price of USD 51 implies the market is overlooking these strengths relative to peers in the financials sector.

Positive factors supporting the valuation include ongoing share repurchases, geographic diversification, and strategic investments in AI to enhance operations. Analysts have highlighted AXA's ability to deliver record underlying earnings and maintain robust margins in commercial lines.

Key Valuation Drivers

• Dividend Sustainability: Forward dividend of USD 2.71 supports attractive income with room for growth.
• Earnings Momentum: Strong Q1 2026 performance and full-year 2025 record results underpin confidence in future profitability.
• Capital Position: High solvency ratio provides flexibility for acquisitions and returns to shareholders.

Main Risks to Consider

Investors should weigh interest-rate volatility, potential regulatory changes in European insurance markets, and currency fluctuations affecting ADR holders. Competition from fintech disruptors and economic slowdowns in key markets also warrant monitoring. However, AXA's diversified portfolio and strong balance sheet help mitigate these factors.

For a deeper look at how these inputs feed into our calculations, explore our fair value calculator.

Balanced Verdict on Axa SA ADR

AXAHY presents a compelling opportunity for value-oriented investors seeking exposure to the insurance sector. With our estimated fair value of USD 71.37 and a meaningful margin of safety, the stock appears undervalued at current levels. The combination of income, growth potential, and solid fundamentals supports a constructive outlook, though prudent position sizing is advisable given sector-specific risks.

Check Axa SA ADR yourself using the free Fair Value Calculator to see live updates and alternative scenarios.

Frequently Asked Questions

Is Axa SA ADR undervalued at current prices?

Yes, our model shows Axa SA ADR trading at a significant discount to fair value of $71.37 from the current price of $51, implying 39.9% upside.

What are the main risks for AXAHY investors?

Key risks include interest rate changes, regulatory shifts in Europe, and competition in the insurance sector, though strong solvency provides a buffer.

When is the next earnings report for Axa SA?

Axa SA is scheduled to report Q2 2026 earnings around July 30-31, 2026, following strong Q1 revenue growth of 6%.

Sources

Context gathered via live web search while writing this article:

• https://stockinvest.us/news/AXAHY
• https://www.investing.com/equities/axa-pk
• https://www.macrotrends.net/stocks/charts/AXAHY/axa-sa/stock-price-history
• https://www.digrin.com/stocks/detail/AXAHY/earnings
• https://www.morningstar.com/stocks/otcm/axahy/quote
• https://www.perplexity.ai/finance/AXAHY/earnings
• https://financhill.com/stock-forecast/axahy-stock-prediction
• https://seekingalpha.com/article/4881033-axa-as-good-as-it-gets

Educational analysis only — not financial advice and not a buy or sell recommendation. Valuations are model-based and may be wrong; past performance does not indicate future results.